Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / IMTX - Immunocore: 'Off-The-Shelf' T Cell Therapy

IMTX - Immunocore: 'Off-The-Shelf' T Cell Therapy

Immatics N.V.
  • Immunocore is a "platform" pharmaceutical company looking to help naïve T cells recognize and kill their targets.
  • Their technology involves soluble TCRs that recognize markers that indicate whether a cell is cancerous or infected with a virus.
  • Their lead asset, tebentafusp, is likely to get approved for a rare deadly cancer known as uveal melanoma.
  • Their platform has generated other assets against different cancer markers and HIV/HBV infected cells, though these are very early stage.

For further details see:

Immunocore: 'Off-The-Shelf' T Cell Therapy
Stock Information
Company Name: Immatics N.V.
Stock Symbol: IMTX
Market: NYSE
Website: immatics.com
Menu
IMTX IMTX Quote IMTX Short IMTX News IMTX Articles IMTX Message Board
Get IMTX Alerts

News, Short Squeeze, Breakout and More Instantly...